#582 Long term follow-up of pelvic organ prolapse repair with abdominal sacrocolpopexy: impact of age and body mass index in a uni-institutional series of 156 patients

Presenter: David Atallah

#583 Incidence and management of mesh related complications in women who received mesh related surgery for pelvic organ prolapse over 11 years in a tertiary unit

Presenter: Osanna Yee Ki Wan

#584 PREDICTING WHETHER CONCOMITTANT ANTERIOR AND/OR POSTERIOR REPAIRS WILL NEED TO BE PERFORMED AT TIME OF UTEROSACRAL LIGAMENT SUSPENSION

Presenter: Jonathan Shepherd

#585 A novel simple laparoscopic needle retractor - Ney-Lift

Presenter: Joerg Neymeyer

#586 Lower urinary tract function improve after laparoscopic sacrocolpopexy in elderly patients with pelvic organ prolapse

Presenter: Mio Togo

#587 Management of post-hysterectomy vaginal vault prolapse: sacrospinous ligament fixation VS iliococcygeus fascia fixation

Presenter: Matteo Frigerio

#588 BSUG Survey of the Management of Pelvic Organ Prolapse in the Elderly, Sexually-inactive Women

Presenter: Wael Agur

#589 Vesico-sphincter function modifications after surgery for pelvic organ prolapse

Presenter: Morena Turco

#590 Urinary Uric Acid Induces Prostatic Inflammation via an Oxidative Stress Pathway

Presenter: Yasuhito Funahashi

#591 Relationship between secondary diagnoses and clinical results after male re-adjustable sling implantation for post-prostatectomy incontinence

Presenter: Bárbara Padilla-Fernández

#592 INCREASED PULSE-WAV VELOCITY AS A RISK FACTOR FOR LOWER URINARY TRACT SYMPTOMS IN MEN

Presenter: Su Jin Kim

#593 Artificial Urinary Sphincter Failure: Characterizing the Causes of Failures and Individual Device Component Survival

Presenter: Arnav Srivastava

#594 Peri-urethral fibrosis related with lower urinary tract symptoms on laparoscopic radical prostatectomy specimen.

Presenter: Youngjun Seo

#595 Relationships between severity of urinary incontinence and physical activity levels in patients who have undergone a general exercise program following prostatectomy

Presenter: Kuan-Yin Lin

#596 Medium term outcomes and safety profile of Botulinum Toxin Type A intra-vesical injections in men with idiopathic detrusor overactivity

Presenter: Sachin Malde

#597 Depending on the type of alpha-AR blockage used in combination with dutasteride, there is a difference in serum PSA decrease rate and prostate volume reduction rate.

Presenter: Tomohiro Magari

#598 Complications of Endoscopic Botulinum Toxin Injection in Patients with AMS 800 Artificial Urinary Sphincter

Presenter: Cristina Gutiérrez

#599 Factors influencing adherence to Tibial Nerve Stimulation for the management of neurogenic overactive bladder

Presenter: Janek Salatzki

#600 Digestive symptoms associated with α1-adrenoceptor antagonists therapy in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)

Presenter: Seiji Matsumoto

#601 Cannabinoid receptor type 2 agonist ameliorates capsaicin-induced prostatitis in the rats

Presenter: Alex Lin

#602 Pharmacological treatment of Lower Urinary Tract Symptoms (LUTS) after a Transurethral Resection of the prostate (TURP) is predictive of a new surgical treatment: 10 years follow-up.

Presenter: Fabiana Cancrini

#603 Complement activation mechanism activated by autoantigen recognition during growth of benign prostatic hyperplasia

Presenter: Junya Hata

#604 OBSERVATIONAL STUDY ON POSTURAL AND BIOMECHANICAL PATTERNS IN PATIENTS UNDERGOING ROBOT ASSISTED RADICAL PROSTATECTOMY WITH AND WITHOUT STRESS URINARY INCONTINENCE

Presenter: Giorgio Donvito

#605 Urinary and fecal incontinence in hospitalized patients: prevalence and associated factors.

Presenter: Vera Lúcia Conceição de Gouveia Santos

#606 The improvement of nocturia after treatment mostly affects the improvement of quality of life.

Presenter: Hyeong Gon Kim

#607 The use of bulbourethral sling in men with post-traumatic incontinence, single center experience

Presenter: Bassem Wadie

#608 The Management of Men with High Pressure Voiding Pdet>100 cm’s H2O before/after Double Therapy

Presenter: Serge Marinkovic

#609 Metabolomic and epigenomic studies provide evidence for “hyperglycemic memory” in diabetic bladder disease

Presenter: Kelvin Davies

#610 Management of nocturia in patients with benign prostate enlargement and overactive bladder symptoms with Solifenacin and Tamsulosin combination treatment versus Tamsulosin monotherapy.

Presenter: Vasileios Sakalis

#611 The influence of night time driving to male lower urinary tract symptom on occupational taxi driver

Presenter: Yongseok Lee

#612 Thyroid hormones in benign prostatic hyperplasia

Presenter: Jun Ho Lee

#613 Change of autonomic nervous activity after treatment with alpha-blocker in men with lower urinary tract symptoms

Presenter: Seol Ho Choo

#614 Analysis of the relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level.

Presenter: Fabiana Cancrini

#615 Using transrectal color Doppler ultrasound to predict deteriorated storage symptoms in patients with benign prostatic hyperplasia after transurethral resection of prostate

Presenter: Saint Chen

#616 Pudendal Nerve Somatosensory Evoked Potentials in patients with postprostatectomy incontinence and erectile dysfunction

Presenter: Kyung Seop Lee

#617 TREATMENT OF URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY WITH RADIOFREQUENCY: NEW CONCEPT

Presenter: Danielle Sodré

#618 Predictive variables of spontaneous micturition recovery after acute urinary retention: an observational prospective study.

Presenter: Marco Vella

#619 A prospective randomaized trial to evaluate the prophylactic use of tadalafil versus tamsulosin for lower urinary tract symptoms and eretile dysfunction after low-dose-rate brachytherapy for prostate cancer: initial report

Presenter: Tomonori Minagawa

#620 The predictive factors for efficacy of initial combination therapy of alpha blocker plus anticholinergic agent in men with benign prostatic hyperplasia and overactive bladder

Presenter: Kwang Woo Lee

#621 Change of urinary NGF expression in LUTS-BPH

Presenter: Ju Tae Seo

#622 In the male rat, only fibrosis of the bladder is found by the castration, however decrease of bladder blood flow and progress of fibrosis are found when complications are added.

Presenter: Tomohiro Magari

#623 Outcomes of Virtue® Sling insertion for post-prostatectomy male stress urinary incontinence.

Presenter: Judith Dockray

#624 Nocturia: Why do People Void at Night?

Presenter: Jerry Blaivas

#625 Correction of renal function by desmopressin and diclofenac in incontinent women with nocturnal polyuria and polyuria

Presenter: Natalya Osipova

#626 Desmopressin Oral Lyophilisate lessens the burden of nocturia in the post-TURP men sooner they go asleep – an action unreachable by fluid restriction alone but attenuated by aging

Presenter: YC Jeremy Teoh

#627 Gender Differences in Prevalence of Nocturia in Patients with Obstructive Sleep Apnea Syndrome (OSAS)

Presenter: Sajjad Rahnama'i

#628 Good functional outcomes after bladder preserving robotic surgery, with or without partial cystectomy, and brachytherapy for muscle-invasive urothelial cell carcinoma of the bladder.

Presenter: Michael van Balken

#629 Patients with nocturnal polyuria presented a different night-time and day-time bladder capacity: implication for nocturia

Presenter: Fabiana Cancrini

#630 Metabolic syndrome and smoking are associated with an increased risk of nocturia in male patients with benign prostatic enlargement.

Presenter: Fabiana Cancrini

#631 PTNS increases time to first nocturnal void and reduces episodes of nocturia in patients with OAB and nocturia.

Presenter: Lambertus Witte

#632 A different way to study frequency volume charts in patients with nocturia.

Presenter: Maarten Declercq

#633 Night-time frequency deteriorate sleep and quality of life: an analysis of international prostate symptom score and sleep questionnaire

Presenter: Yosuke Matsuta

#634 Resolved stress and urge incontinence in women with MUI after mid-urethral sling surgery based on variable positioning urodynamic evaluation

Presenter: Hikaru Tomoe

#635 Effectiveness of Conservative Therapy in Idiopathic Overactive Bladder

Presenter: Abeer El Zohiery

#636 Age-related differences of bladder sensations in OAB patients

Presenter: Alexandra Herrewegh

#637 THE MANAGEMENT OF OVERACTIVE BLADDER IN DAILY PRACTICE IN TURKEY: PRELIMINARY REPORT OF THE TURKISH CONTINENCE SOCIETY MULTICENTRIC STUDY

Presenter: Ali Ersin Zümrütbas

#638 Minimal Clinically Important Difference for the International Consultation on Incontinence Questionnaire-Overactive bladder (ICIQ-OAB).

Presenter: Tina Sara Verghese

#639 The molecular mechanism of autophagy via mitochondrial and endoplasmic reticulum pathway in ketamine-induced ulcerative cystitis in animal model

Presenter: Yung-Shun Juan

#640 Safety and effectiveness of mirabegron in patients ≥75 yrs with overactive bladder: analysis of a Japanese post-marketing commitment study

Presenter: Masaki Yoshida

#641 PERSISTENCE WITH MIRABEGRON THERAPY IN PATIENTS WITH OAB IN A MULTICENTER CLINICAL STUDY

Presenter: Alois Martan

#642 Comparison of two different drugs for overactive bladder, Solifenacin succinate and Mirabegron : A prospective randomized crossover study

Presenter: Miyabi Inoue

#643 Prevalence rates of urodynamic stress incontinence, bladder oversensitivity/detrusor overactivity or both and their urodynamic and clinical findings in women with ≥stage II cystocele

Presenter: Sheng-Mou Hsiao

#644 Electrical Stimulation of Afferent Nerves in the Foot with Transcutaneous Adhesive Pad Electrodes in Women with OAB: Comparison of Different Stimulation Durations

Presenter: Christopher Chermansky

#645 Subtrigonal Botulinum toxin-A (BoNT-A) therapy for female patients with OAB combined with urethral instability - results of a pilot study

Presenter: Janneke van Uhm

#646 Mirabegron and succinate in the control of bladder contraction

Presenter: Philippe Cammisotto

#647 The Short-Term Effect of Functional Magnetic Stimulation on Symptoms of Refractory Neuropathic Overactive Bladder Syndrome in Women

Presenter: Tamara Serdinšek

#648 An evaluation of the OAB-V8 using item response theory

Presenter: Trafford Crump

#649 THE VALUE OF COMBINING LOW DOSE TROSPIUM CHLORIDE WITH TRANSCUTANEOUS POSTERIOR TIBIAL NERVE STIMULATION IN THE TREATMENT OF OVERACTIVE BLADDER IN FEMALES

Presenter: Amr Abulseoud

#650 Baseline characteristics of patients initiating mirabegron or antimuscarinics treatment for overactive bladder: Results from the PERSPECTIVE Registry

Presenter: Eric Rovner

#651 The GPR91 receptor is activated in the urothelium and involved in detrusor contractility

Presenter: Abubakr Mossa

#652 BlueWind Medical RENOVA™ system long-term safety and performance in treatment of patients diagnosed with overactive bladder (OAB)

Presenter: John Heesakkers

#653 Long Term Compliance and Results of Intravesical Botulinum Toxin A Injections in Male Patients

Presenter: Tom Marcelissen

#654 Validity and Reliability in Overactive Bladder (OAB) Symptom Score in Thai version (OABSS-T)

Presenter: Chavalit Honglertsakul

#655 Association between irritable bowel syndrome and overactive bladder: research survey

Presenter: Kyu Shik Kim

#656 PATIENT PREFERENCE, SAFETY AND EFFICACY OF MIRABEGRON VS SOLIFENACIN IN PATIENTS WITH PELVIC ORGAN PROLAPSE AND OVERACTIVE BLADDER: A RANDOMIZED CROSSOVER PILOT STUDY

Presenter: Kumiko Kato

#657 Medical and surgical treatments for urge urinary incontinence: URGE 1 - A randomized, comparative clinical trial

Presenter: Sebastian Dr.Ludwig

#658 Association of Advanced Glycation End-products Accumulation with Overactive Bladder Syndrome in Japanese Community-dwelling Elderly

Presenter: Kenji Omae

#659 Mirabegron 50 mg vs. mirabegron 100 mg vs. tolterodine 4 mg in reducing nocturia and urgency episodes in patients with Overactive Bladder/storage LUTS: a systematic review and meta-analysis

Presenter: Arcangelo Sebastianelli

#660 Antimuscarinic Use in Females with Overactive Bladder Syndrome Increases the Risk of Depressive Disorder: A Three-year Follow-up Study

Presenter: Chin Fong Au

#661 EXPLORING THE BACTERIAL URINARY ECOLOGY IN PATIENTS WITH OVERACTIVE BLADDER SYMPTOMS

Presenter: Kiren Gill

#662 Analysis of patients with bladder dysfunction and renal transplantation: a single center experience

Presenter: Enric Miret

#663 Constipated adolescents at higher risk for having daytime urinary incontinence: a community-based study

Presenter: Shang-Jen Chang

#664 Nocturnal enuresis in paediatric patients: exploring the role of the overactive bladder and of antimuscarinic treatment. A single centre experience.

Presenter: Konstantinos Vaios Mytilekas

#665 Lower Urinary Tract Dysfunction With Vesicoureteral Reflux: A More Significant Factor Predicting Recurrent Febrile UTI in Infants.

Presenter: Chia Cheng Su

#666 Outcome after urotherapy in children with dysfunctional voiding on symptoms and quality-of-life.

Presenter: Toscane Noordhoff

#667 Extracorporeal Magnetic stimulation versus Posterior tibial nerve stimulation in the treatment of refractory monosymptomatic nocturnal enuresis: a prospective randomized study.

Presenter: Osama Abdelwahab

#668 The impact of readiness on the acquisition of bladder control: a pilot study

Presenter: Kelly Van der Cruyssen

#669 Intra detrusor injections of botulinum toxin type A in children with spina bifida: a multicentric study

Presenter: Juliette Hascoet

#670 PSA concentration change in men taking low dose finasteride and dutasteride for male androgenetic alopecia

Presenter: Yong-June Kim

#671 Value of Enucleation-Morcellation Efficacy to Predict the Learning Curve of Holmium Laser Enucleation of the Prostate for Treatment of Benign Prostatic Hyperplasia

Presenter: Sung Tae Cho

#672 Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner’s lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)

Presenter: Masakatsu Ueda

#673 Pubis-rectum length is a novel factor associated with early recovery of continence following robot-assisted laparoscopic prostatectomy.

Presenter: Hiroshi Kiuchi

#674 Difference of Electrical Impedance between Typical Benign Prostatic Hyperplasia Tissues and Beach Balls Retrieved after Holmium Laser Enucleation of the Prostate

Presenter: Hyeon Woo Kim

#675 Antegrade bilateral nerve sparing radical prostatectomy: a matched pair analysis of open vs. robot-assisted approach from a single tertiary referral center

Presenter: Arcangelo Sebastianelli

#676 ANTEGRADE MONOLATERAL NERVE SPARING RADICAL PROSTATECTOMY: A PROSPECTIVE SINGLE CENTER STUDY TO ASSESS FUNCTIONAL OUTCOMES OF OPEN VS. ROBOT ASSISTED APPROACH

Presenter: Arcangelo Sebastianelli

#677 Pathological Findings In Urethral Diverticulum And Possible Pathogenesis Of Urethral Diverticulum Cancer

Presenter: Christina Fontaine

#678 Surgical and patient reported outcomes of artificial urinary sphincter implantation- a multicentre prospective observational study

Presenter: Yasuhiro Kaiho

#679 Predictors of success in urethroplasty

Presenter: Judith Dockray

#680 Anterior vaginal mucosal flap approach for female urethral reconstruction in patients with urethral stricture

Presenter: Sakineh Hajebrahimi

#681 Automatic reference height correction for a water-filled urodynamic system

Presenter: Alexandra Bacon

#682 ASSOCIATION BETWEEN CONVENTIONAL URODYNAMICS, CHARACTERISTIC VARIABLES OF PATIENT PROFILE, AND SPECIFIC TYPE OF URINARY INCONTINENCE IN FEMALE PATIENTS

Presenter: Zane Pilsetniece

#683 Is the lateral projection superior to Antero-Posterior for Video-urodynamics in Children?

Presenter: Shehryer Naqvi

#684 Predicting bladder outlet obstruction in men with persistent overactive bladder symptoms after medical treatment for lower urinary tract symptoms

Presenter: Chung-Cheng Wang

#685 Retrospective analysis of Urodynamic Results in Female Patients with Stress Urinary Incontinence, Large Post Void Residual Urine and Abnormal Non Invasive Flowmetry

Presenter: Aldo Tosto

#686 Maximum urinary flow differences between free-flow and pressure-flow study in women: effect of bladder outlet obstruction versus detrusor underactivity.

Presenter: Vaios Konstantinos Mytilekas

#687 Post void residual urine ratio compared to post void residual urine in males with Lower Urinary Tract Sympthoms.

Presenter: Rita Righetti

#688 Are urodynamics useful prior to surgical treatment for advanced pelvic organ prolapse?

Presenter: Lucas Abrahão

#689 Videourodynamic findings of interstitial cystitis and the association with clinical characteristics

Presenter: Yuh-Chen Kuo

#690 BIOCOMPUTATIONAL MODEL FOR URODYNAMICS ANALYSIS

Presenter: Dulce Oliveira

#691 The effect of a 6 Ch urodynamic catheter on Maximum flow rate of pressure /flow study. Does it cause any obstruction?

Presenter: Diamantis Floratos

#692 Do urodynamics predict urinary retention after sling placement in the complex patient? The value of reproducing symptoms on urodynamics

Presenter: Alyssa Greiman

#693 The morphological characteristics of the bladder contraction in female

Presenter: Chiharu Shibata

#694 CLINICAL SCORE PREDICTIVE OF THE ABDOMINAL LEAK POINT PRESSURE (ALPP) <60 CM H2O IN WOMEN WITH STRESS URINARY INCONTINENCE.

Presenter: Leandro Arribillaga

#695 Does the choice of Cystometry Catheter affect Urodynamic Diagnosis?

Presenter: Alison Mackay

#696 Videourodynamic Characteristics of Detrusor Underactivity in Women with Voiding Dysfunction

Presenter: Tsai-Hwa Yang

#697 Urodynamic evaluation in male patients with diabetes mellitus

Presenter: Tsuyoshi Majima

#698 Is the sensitivity of T-DOC air charged catheters stable enough for ambulatory urodynamic monitoring?

Presenter: James Blake

#699 The definition of detrusor after-contraction: who cares?

Presenter: Alison Bray

#700 NO PAIN, LOTS OF GAIN: TOPICAL LIDOCAINE FOR URODYNAMIC TESTING, DOUBLE BLINDED RCT

Presenter: Kristine Zinkgraf

#701 How to Assess Maximum Voided Volume: Comparison Of Maximum Voided Volume Obtained During Uroflow To Maximum Voided Volume Obtained By Frequency Volume Chart

Presenter: Jerry Blaivas

#702 INSENSIBLE URINE LOSS, POST-MICTURITION DRIBBLING, NOCTURNAL ENURESIS, AND COITAL INCONTINENCE: WHAT DOES URINARY INCONTINENCE MEAN TODAY?

Presenter: Carolyn Botros

#703 Urodynamics parameters and Metabolic syndrome: prospective pilot study

Presenter: Omar Saleh

#704 Comparative analysis of parameters to evaluate the severity of urinary incontinence: a prospective study

Presenter: Min-Young Yoon

#705 What has head to head comparison of fluid versus air filled pressure systems during clinical cystometry and pressure flow measurement learnt us?

Presenter: Peter Rosier

#706 Incidence of lower urinary tract dysfunctions in diabetic patients placed on the waiting list for a combined kidney and pancreas transplantation and their relationship to the severity of diabetes mellitus.

Presenter: Jan Mokris

#707 Technical Performance of the T-DOC® Air-Charged Catheters – an Alternative Technology for Urodynamic Studies

Presenter: Ing Goping